The largest database of trusted experimental protocols

7 protocols using s2619

1

Cell Line Culture and Manipulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
LNCaP, LNCaP-LN3, C4, C4–2, C4–2B, PC-3M, PC-3M-LN4, PC-3M-Pro4, and MDA-MB453 cells were grown as previously described [30 (link), 67 (link)]. The HEK293T, PC3, and C4–2 cells were cultured in DMEM supplemented with 10% fetal calf serum, 1% penicillin, and 1% streptomycin. The DNA methylase inhibitor 5-Aza-dC (10 μM) (#A3656, Sigma), the 26S proteasome inhibitors MG132 (20 μM) (#S2619, Selleckchem), or N-acetyl-L-leucyl-L-leucyl-L-nor leucinal (LLNL) (25 μM) (#A6185, Sigma), Doxorubicin (Sigma), Talazoparib (SeleckChem), NU7026 (Sigma) were used as described in the text. TGF-β receptor type I (TGF-βRI) kinase inhibitors LY2157299 and LY363947 were bought from Selleckchem.
The expression vectors encoding DACH1 [69 (link)], Ku70 (RFP-Ku70) and Ku80 (RFP-Ku80) [70 (link)], shDACH1[71 (link)] were previously described. The EGFP-DACH1 expression plasmid was made by inserting the human DACH1 cDNA into the HindIII and BamHI sites of the pEGFP-C1 vector.
+ Open protocol
+ Expand
2

Hypoxia-Induced Mitochondrial Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary PASMCs were quiesced in serum-free medium for 24 h and then exposed to normoxia (21% O2) and hypoxia (5% O2) in the absence or presence of mitochondria-targeted antioxidant MitoQ (0.5 μM, HY-100116A, MCE), chetomin (50 nM, GC17405, GlpBio), MG-132 (10 μM, S2619, Selleck), H2O2 (50, 75, and 100 mM, Beyotime), DCA (10 mM, 347795, Sigma–Aldrich), lactate (10 mM, 71718, Sigma–Aldrich), and sodium oxamate (50 μM, GC44911, GlpBio). After indicated time periods, the relative changes in mRNA, protein, metabolites, and proliferation capacity were assessed through corresponding methods. The concentrations of these compounds were chosen according to previous studies.
+ Open protocol
+ Expand
3

Protein Interaction Assays and Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
As previously mentioned co-IP and His pull-down assays were performed [32 (link)]. Cycloheximide (CHX, 20 μg/mL, MedChemExpress) and/or MG132 (20 μM, S2619, Selleck) were added to dishes at the specified concentrations for the indicated periods, accomplished by western blotting.
+ Open protocol
+ Expand
4

Evaluating Myc-PTX3 Protein Stability

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSCs or 293T cells were seeded into six‐well plates at a density of 3 × 105 cells/well. The cells were treated with the lysosomal inhibitor chloroquine (50 μM; 14774; CST) or the proteasomal inhibitor MG132 (10 μM; S2619; Selleck) or MG101 (10 μM; S7386; Selleck) for another 12 hours to block the autophagy‐lysosome pathway (ALP) or UPS. Protein lysates were subsequently harvested, and the level of the Myc‐PTX3 protein was evaluated using Western blotting.
+ Open protocol
+ Expand
5

Optimizing Plant Seedling Transfer and Treatment Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Generally, to avoid manipulation-related effect during plant transfer from solid to liquid medium, we transferred the seedlings into liquid 1/2 MS medium and preincubated them for 12 hours before treatment.
The procedure for CRD treatment was as described [68 (link)]. The 7-DAG seedlings were collected and placed in incubation buffer (1 mM pipes [pH 6.25], 1 mM sodium citrate, 1 mM KCl, 15 mM sucrose), 200 μM CRD (C3394, Sigma-Aldrich), with or without 1 µM RALF1. The samples were infiltrated under vacuum for 3 minutes in incubation buffer, followed by incubation in 23°C for indicated times. Then, plant samples were harvested for RNA extraction.
Treatment of plants with MG132 and CHX was conducted as described [69 (link)]. Seven-day-old Col-0 and fer-4 seedlings grown on 1/2 MS agar plates were collected and transferred to liquid MS medium (with or without 1 µM RALF1) in the presence or absence of 50 μM MG132 (S2619, Selleckchem) or 100 μM CHX (01810, Sigma-Aldrich) for 2 hours. Whole-plant samples were harvested and frozen in liquid nitrogen for protein extraction and immunoblot assay.
+ Open protocol
+ Expand
6

BMP2/4 and LSD1 Inhibition Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were pre‐treated with either active BMP2 recombinant protein (10 ng/ml, 355‐BM‐010, Bio‐Techne Ltd), active BMP4 recombinant protein (10 ng/ml, 120‐05‐ET, PeproTech), ORY‐1001 (1 μM), GSK‐LSD1 (1 μM), or DMSO for 24 h. Prior to protein extraction, each condition was split and was either co‐treated with the proteasome inhibitor MG‐132 (1 μM, S2619, Selleck Chemicals) or DMSO for 2 h. Cells were pelleted, washed with PBS, and lysed with RIPA buffer as described above. Immunoblotting was conducted according to standard procedures.
+ Open protocol
+ Expand
7

Mesangial Cell Culture and Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mouse glomerular mesangial SV40-MES-13 cell line (Fuxiang Biotechnology Company, Shanghai, China, ATCC number CRL-1927) was cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 100 units/mL penicillin, 100 mg/mL streptomycin, and 10% fetal bovine serum. Confluent cells were cultured in serum-free DMEM media for 24 h before the experiments. The cells were divided into the normal group (NG, 5.56 mM), the vehicle control group (DMSO, 0.05%, D5879, Sigma, St. Louis, MO, USA), the HG group (HG, 30 mM, G7021, Sigma), the HG + low-dose AB38b group (AB38bL + HG, 2.5 μM), the HG + medium-dose AB38b group (AB38bM + HG, 5 μM), the high glucose + high-dose AB38b group (AB38bH + HG, 10 μM), the high glucose + resveratrol (5010, Sigma) positive control group (Res + HG, 10 μM), the sulforaphane positive control group (S4441, Sigma) and the MG132 positive control group (S2619, Selleckchem, Houston, TX, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!